21 CFR 357.203
§ 357.203 Definition.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 357.203, § 357.203 Definition, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/86722
- Permanent ID
ys:prov:86722@1- SHA-256
ae15fdc50bbff237710791e364337d5c727939e6e58b8233d136ad3fcb77d3e5
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
As used in this subpart:
Cholecystokinetic drug product. A drug product that causes contraction of the gallbladder and is used during the course of diagnostic gallbladder studies (cholecystography).
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.